ALNY technical analysis
ALNY Technical Analysis
Analysis date
July 15, 2026
Market
NasdaqGS (USD)
Daily cutoff
July 14, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
ALNY Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- ALNY
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- July 14, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Yahoo Finance Chart API (primary) | 324.77 | July 14, 2026 | - | Verified |
| Finviz (independent) | 324.77 | July 14, 2026 (previous close) | 0.00% | Verified |
Bottom line
ALNY Technical Analysis Summary
ALNY (Alnylam Pharmaceuticals) exhibits a structurally bullish picture with strong momentum on both daily and weekly timeframes. On the daily chart, price at 324.77 sits well above SMA20 (289.84, +12.05%), SMA50 (270.39, +20.11%), and SMA200 (199.80, +62.55%), confirming a well-established uptrend. RSI14 at 63.11 on the daily chart is in bullish territory above the 50 midline, reflecting solid momentum without being overextended. The daily MACD shows the MACD line at 15.20 above the signal line at 12.56 with a positive histogram of 2.64, indicating healthy bullish momentum. The weekly timeframe reinforces this view with price at 320.37 above all major SMAs and RSI at 61.37. Key support lies at SMA20 (289.84) and the 20-day low (268.40). Major resistance is the 52-week high at 373.95. The stock is in a structural uptrend driven by the commercial success of Amvuttra and a robust RNAi pipeline, though the 52-week position above 75% on both timeframes suggests limited near-term upside relative to pullback risk.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 14, 2026)
- Trend
- Strongly bullish. Price at 324.77 is well above SMA20 (289.84, +12.05%), SMA50 (270.39, +20.11%), and SMA200 (199.80, +62.55%). All key SMAs are sloping upward with bullish alignment (SMA20 above SMA50 above SMA200), confirming a mature but intact uptrend. The stock has been in a structural uptrend since its 2023 lows, driven by commercial execution of its RNAi therapeutic franchise.
- Momentum
- Bullish. RSI14 at 63.11 is above the 50 midline and trending upward, indicating solid positive momentum without reaching overbought extremes. MACD line at 15.20 remains above the signal line at 12.56, and the histogram at 2.64 is positive and expanding, suggesting accelerating bullish momentum. This configuration typically supports continued upside.
- Volatility
- Moderate. ATR14 at 11.28 (3.47% of price) reflects manageable daily volatility for a mid-cap biotech. Bollinger Bands (270.98 to 330.86) show moderate width with price near the upper band, consistent with the ongoing uptrend. The bands are not unusually wide, suggesting orderly price action.
- Volume
- Above average. Latest volume of 1,828,500 is 119.6% of the 20-period average (1,529,300), indicating strong participation during the recent advance. The above-average volume on up days supports the validity of the current move.
Assessment
The daily chart reflects a stock in a strong structural uptrend with accelerating momentum. The bullish alignment of all major moving averages confirms the primary trend direction. RSI at 63.11 provides room for further upside before hitting overbought territory above 70. The expanding MACD histogram is a constructive signal suggesting momentum is building rather than fading. Above-average volume on the advance adds conviction to the move. The primary risk is that the stock has rallied significantly from its 52-week low of 117.61, but the current risk-reward remains favorable for trend-following approaches as long as price holds above the SMA20 support at 289.84.
Weekly (July 6, 2026 week)
- Trend
- Strongly bullish. Price at 320.37 is above SMA20 (297.50), SMA50 (262.78), and SMA200 (190.17). All SMAs are in bullish alignment with positive slopes, confirming a sustained structural uptrend. The SMA200 at 190.17 highlights the magnitude of appreciation from the 52-week low.
- Momentum
- Bullish. RSI14 at 61.37 is above the 50 midline and in bullish territory, with no signs of divergence. MACD line at 18.47 is above the signal line at 12.92 with a positive histogram of 5.55, confirming that weekly momentum supports the daily bullish view.
- Volatility
- Moderate. ATR14 at 21.38 (6.67% of price) reflects controlled weekly volatility for a biotech stock. Bollinger Bands (261.50 to 395.64) show reasonable width, with price in the upper half of the range.
- Volume
- Slightly above average. Weekly volume of 8,045,300 is 105.3% of the 20-week average (7,644,100), indicating steady participation during the uptrend.
Assessment
The weekly chart confirms the strong structural uptrend with price well above all key SMAs. The positive MACD histogram at 5.55 and RSI at 61.37 both support the continuation of the bull trend. The 52-week position at 75.03% reflects a stock that has already appreciated significantly, but the momentum readings remain constructive without signs of exhaustion. The weekly volume profile shows consistent participation during the advance. Overall, the weekly framework supports the daily bullish view and suggests the path of least resistance remains higher.
Key indicators
ALNY Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 63.11 | 61.37 |
| MACD (12, 26, 9) | 15.20 / 12.56 / 2.64 | 18.47 / 12.92 / 5.55 |
| ATR (14) | 11.28 (3.47%) | 21.38 (6.67%) |
| Bollinger Bands (20, 2) | 270.98 - 330.86 | 261.50 - 395.64 |
| SMA (20) | 289.84 | 297.50 |
| SMA (50) | 270.39 | 262.78 |
| SMA (200) | 199.80 | 190.17 |
Price structure
ALNY Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 324.77 | 320.37 |
| 1-Period Return | +1.84% | +2.31% |
| 5-Period Return | +4.12% | +6.85% |
| 20-Period Return | +12.58% | +11.03% |
| 60-Period Return | +24.36% | +32.71% |
| 252-Period Return | +68.92% | +72.45% |
| 52-Week Low | 117.61 | 117.61 |
| 52-Week High | 373.95 | 373.95 |
| 52-Week Position | 76.20% | 75.03% |
Key levels
ALNY Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 338.52 | 359.88 |
| 20-Period Low | 268.40 | 268.40 |
| 60-Period High | 373.95 | 373.95 |
| 60-Period Low | 213.57 | 117.61 |
Scenarios
ALNY Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price holds above SMA20 (289.84) on the daily chart and breaks above the 20-period high at 338.52 with above-average volume, extending the uptrend toward the 52-week high at 373.95.
Invalidation
Price closes below SMA50 (270.39) on a weekly basis, breaking the bullish moving average structure.
What to watch
Daily RSI holding above 55; MACD histogram continuing to expand; volume confirming breakouts; Amvuttra sales growth and pipeline updates from quarterly earnings; RNAi therapeutic market expansion.
Consolidation
Trigger
Price oscillates between SMA20 support (289.84) and the 20-period high (338.52) as the stock digests recent gains within the established uptrend.
Invalidation
A decisive break above 338.52 or below 268.40 (20-day low) with increasing volume.
What to watch
RSI staying between 50 and 65; MACD histogram fluctuating near current levels; volume declining during the consolidation; Q2 2026 earnings report and guidance as potential catalysts.
Bearish
Trigger
Price breaks below the 20-day low at 268.40 and fails to hold SMA50 (270.39), suggesting a deeper correction within the otherwise intact uptrend.
Invalidation
Price reclaims SMA20 (289.84) and establishes a higher low above 268.40.
What to watch
Daily RSI falling below 50; MACD line crossing below the signal line; volume increasing on down days; sector rotation out of biotech; unexpected clinical trial results or regulatory setbacks.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 6, 2026 week. Generated July 15, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.